In a fast-evolving pharmaceutical industry, innovation and collaboration are key to staying ahead. At Parimer, our focus is combining advanced research with practical solutions to create a good product. Some ways that we do this is through: ?? Driving R&D Forward: From designing new compounds and polymers to developing innovative drug delivery systems, our work helps address complex challenges in drug development. ?? Commitment to Improvement: Enhancing existing drugs and refining manufacturing processes are central to our efforts to help partners improve efficiency and meet industry demands. ?? A Transparent Approach to Patents: Our intellectual property policies allow partners to retain ownership of their innovations, fostering trust and enabling unrestricted commercialization. ?? Connecting Research to Application: With advanced facilities and expertise, we can help bridge the gap between lab research and market-ready solutions, offering support for a range of pharmaceutical needs. ?? Collaborative Partnerships: By working closely with academia, startups, and industry leaders, we aim to contribute to meaningful advancements in drug development. Read more about how our approach - https://lnkd.in/gz39Y3XZ
Parimer Scientific的动态
最相关的动态
-
?? The future of pharmaceutical and life sciences lies in reimagining processes and organizations. Next-Gen Global Business Services centers can revolutionize the industry by unleashing productivity, accessing global talent pools, improving technology investments, accelerating insights, and achieving dramatic cost improvements. Learn how this model can help transform your pharma and life sciences enterprise.
Next-Gen Global Business Services transforms how pharma companies deliver work
要查看或添加评论,请登录
-
?? The future of pharmaceutical and life sciences lies in reimagining processes and organizations. Next-Gen Global Business Services centers can revolutionize the industry by unleashing productivity, accessing global talent pools, improving technology investments, accelerating insights, and achieving dramatic cost improvements. Learn how this model can help transform your pharma and life sciences enterprise.
Next-Gen Global Business Services transforms how pharma companies deliver work
要查看或添加评论,请登录
-
?? The future of pharmaceutical and life sciences lies in reimagining processes and organizations. Next-Gen Global Business Services centers can revolutionize the industry by unleashing productivity, accessing global talent pools, improving technology investments, accelerating insights, and achieving dramatic cost improvements. Learn how this model can help transform your pharma and life sciences enterprise.
Next-Gen Global Business Services transforms how pharma companies deliver work
要查看或添加评论,请登录
-
?? The future of pharmaceutical and life sciences lies in reimagining processes and organizations. Next-Gen Global Business Services centers can revolutionize the industry by unleashing productivity, accessing global talent pools, improving technology investments, accelerating insights, and achieving dramatic cost improvements. Learn how this model can help transform your pharma and life sciences enterprise.
Next-Gen Global Business Services transforms how pharma companies deliver work
要查看或添加评论,请登录
-
More than 40 industry executives shared their views on where the biopharma industry stands as it enters the new year. Innovation remains the sector’s driving force, but after two years of capital constraint, due diligence is key.
Scrip Asks… What Does 2025 Hold For Biopharma? Part 1: The State Of The Biopharma Industry
insights.citeline.com
要查看或添加评论,请登录
-
???? The power of patents in fueling innovation across biotech, tech, and pharma! ?? From protecting R&D investments to driving breakthrough technologies and treatments, patents provide exclusive rights, incentivize creativity, and enable valuable collaborations. ?? With market exclusivity and public disclosure, patents ensure progress and continued advancement in research! #ExyIP #Patent #intellectualproperty #Innovation #ResearchAndDevelopment #Biotech #Pharma #Tech #Collaboration
要查看或添加评论,请登录
-
ARTICLE – The future of #pharma is being reshaped through collaboration and cutting-edge technology. Experts from Bristol Myers Squibb, Emerson's Automation Technologies & Solutions and FUJIFILM Diosynth Biotechnologies share the role that each of the companies play in shortening the time it takes to get drugs to market faster. The impact of trust and technology, changes in manufacturing to accelerate time to market, and automation at the core are a few topics discussed in this article. Read the full article in Pharma Manufacturing https://ow.ly/PhQo30sGagI #software #analytics
Accelerating the pharma pipeline is a shared journey
pharmamanufacturing.com
要查看或添加评论,请登录
-
ARTICLE – The future of #pharma is being reshaped through collaboration and cutting-edge technology. Experts from Bristol Myers Squibb, Emerson's Automation Technologies & Solutions and FUJIFILM Diosynth Biotechnologies share the role that each of the companies play in shortening the time it takes to get drugs to market faster. The impact of trust and technology, changes in manufacturing to accelerate time to market, and automation at the core are a few topics discussed in this article. Read the full article in Pharma Manufacturing https://ow.ly/WulL30sG8Pa #software #analytics
Accelerating the pharma pipeline is a shared journey
pharmamanufacturing.com
要查看或添加评论,请登录
-
ARTICLE – The future of #pharma is being reshaped through collaboration and cutting-edge technology. Experts from Bristol Myers Squibb, Emerson's Automation Technologies & Solutions and FUJIFILM Diosynth Biotechnologies share the role that each of the companies play in shortening the time it takes to get drugs to market faster. The impact of trust and technology, changes in manufacturing to accelerate time to market, and automation at the core are a few topics discussed in this article. Read the full article in Pharma Manufacturing https://ow.ly/Eteq30sGamk #software #analytics
Accelerating the pharma pipeline is a shared journey
pharmamanufacturing.com
要查看或添加评论,请登录
-
ARTICLE – The future of #pharma is being reshaped through collaboration and cutting-edge technology. Experts from Bristol Myers Squibb, Emerson's Automation Technologies & Solutions and FUJIFILM Diosynth Biotechnologies share the role that each of the companies play in shortening the time it takes to get drugs to market faster. The impact of trust and technology, changes in manufacturing to accelerate time to market, and automation at the core are a few topics discussed in this article. Read the full article in Pharma Manufacturing https://ow.ly/9IlG30sG8Cq #software #analytics
Accelerating the pharma pipeline is a shared journey
pharmamanufacturing.com
要查看或添加评论,请登录
Solomon Brown